Literature DB >> 15746567

Serum cytokine receptor levels in noninfectious uveitis.

Necip Torun1, Josep Callizo, Natasa Orlic, Matthias Scherer, Christian Hartmann, Uwe Pleyer.   

Abstract

PURPOSE: Understanding of the role of cytokines in uveitis may provide new clues to its treatment. Therefore, the purpose of our study was to evaluate systemic cytokine receptor expression in patients with noninfectious uveitis.
METHOD: Serum concentrations of soluble interleukin-2 receptor alpha (IL-2 s Ralpha) and soluble tumor necrosis factor receptor-1 (sTNF-R1) were measured in patients with intermediate uveitis (n = 26), posterior uveitis (n = 23) and healthy controls (n = 12) using ELISA. All patients were identified in a consecutive series of 996 uveitis patients who had been diagnosed between 1998 and 2002 and classified according to the recommendations of the International Uveitis Study Group. Inclusion criteria were idiopathic, active intraocular inflammation, uveitis as a primary process and no systemic anti-inflammatory treatment at the time of blood sampling. None of the patients had an underlying systemic disease.
RESULTS: Serum concentrations of IL-2 s Ralpha were significantly increased in patients with posterior (p < 0.005) and intermediate uveitis (p < 0.005) as compared to healthy controls. Similarly, concentrations of sTNF-R1 appeared to be increased in posterior (p < 0.005) and intermediate (p < 0.005) uveitis patients when compared to controls.
CONCLUSIONS: Our results may suggest that patients with noninfectious uveitis express systemic cytokine receptors such as TNF-R1 and IL-2 Ralpha, which may have an important role in the immune response of the eye and may lead to new immunomodulatory approaches. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15746567     DOI: 10.1159/000084271

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  5 in total

1.  [Biologics in ophthalmology].

Authors:  U Pleyer
Journal:  Ophthalmologe       Date:  2011-01       Impact factor: 1.059

Review 2.  Advances in the diagnosis and immunotherapy for ocular inflammatory disease.

Authors:  Steven Yeh; Lisa J Faia; Robert B Nussenblatt
Journal:  Semin Immunopathol       Date:  2008-03-05       Impact factor: 9.623

3.  Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis.

Authors:  Enken Gundlach; Michael Marcus Hoffmann; Antje Prasse; Sonja Heinzelmann; Thomas Ness
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

4.  Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT.

Authors:  Rose M Gilbert; Xiaozhe Zhang; Robert D Sampson; Michael R Ehrenstein; Dao X Nguyen; Mahid Chaudhry; Charles Mein; Nadiya Mahmud; Grazyna Galatowicz; Oren Tomkins-Netzer; Virginia L Calder; Sue Lightman
Journal:  Front Immunol       Date:  2018-05-03       Impact factor: 7.561

5.  Systemic Regulatory T Cells and IL-6 as Prognostic Factors for Anatomical Improvement of Uveitic Macular Edema.

Authors:  Jessica Matas; Victor Llorenç; Alex Fonollosa; David Díaz-Valle; Cristina Esquinas; Maria Teresa Sainz de la Maza; Marc Figueras-Roca; Joseba Artaraz; Barbara Berasategui; Marina Mesquida; Alfredo Adán; Blanca Molins
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.